Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT07168902

Public ClinicalTrials.gov record NCT07168902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Evaluation of the Safety, Ocular Tolerability, and Efficacy of Topical Ophthalmic BL1107 Versus Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension

Study identification

NCT ID
NCT07168902
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
252 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2025 (Actual)
Primary completion
May 18, 2026 (Actual)
Completion
May 18, 2026 (Actual)
Last update posted
Jul 22, 2026

2025 – 2026

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Global Research Management, Inc. Glendale California 91204 —
Eye Research Foundation Newport Beach California 92663 —
California Eye Specialist Medical Group, LLC Pasadena California 91107 —
Eye Associates of Fort Myers Fort Myers Florida 33901 —
Levenson Eye Associates Jacksonville Florida 32204 —
Central Florida Eye Associates Lakeland Florida 33805 —
Lee Shettle Eye and Hearing Largo Florida 33773 —
Clayton Eye Clinical Research, LLC Morrow Georgia 30260 —
Coastal Research Associates, LLC Roswell Georgia 30076 —
Heart of America Eye Care Shawnee Mission Kansas 66204 —
Andover Eye Associates Andover Massachusetts 01810 —
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066 —
Total Eye Care, P.A. Memphis Tennessee 38119 —
Houston Eye Associates Houston Texas 77025 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07168902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07168902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →